Alpha Cognition (ACOG) Stock Price, News & Analysis

Company Overview

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $5.90 to $6.68
• 50-Day Range: N/A
• 52-Week Range: $4.66 to $7.00
• Volume: 67,491 shs
• Average Volume: 100,963 shs
• Market Capitalization: $100.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACOG Stock Analysis - Frequently Asked Questions

How have ACOG shares performed this year?

Alpha Cognition's stock was trading at $5.86 at the start of the year. Since then, ACOG shares have increased by 7.2% and is now trading at $6.28.
View the best growth stocks for 2025 here.

When did Alpha Cognition IPO?

Alpha Cognition (ACOG) raised $50 million in an initial public offering on Tuesday, November 12th 2024. The company issued 8,695,653 shares at $5.75 per share.

Who are Alpha Cognition's major shareholders?

Top institutional shareholders of Alpha Cognition include Solas Capital Management LLC (8.70%), Sphera Funds Management LTD. (3.87%), Alyeska Investment Group L.P. (2.50%) and Altium Capital Management LLC (1.72%).

How do I buy shares of Alpha Cognition?

Shares of ACOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 2/22/2025
• Next Earnings (Estimated): 4/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ACOG
• CUSIP: N/A
• CIK: 1655923
• Web: N/A
• Phone: (858) 344-4375
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.56)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-13,770,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -344.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.50
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.08) per share
• Price / Book: -5.81

Miscellaneous

• Outstanding Shares: 16,020,000
• Free Float: 10,970,000
• Market Cap: $100.61 million
• Optionable: N/A
• Beta: 2.53